Aebeze Labs, Inc. — Department of Defense SBIR Phase I: AF191-005
Aebeze Labs, Inc. — SBIR Phase I award from Department of Defense.
- Amount
- $41,094
- Agency
- Department of Defense · Air Force
- Program / Phase
- SBIR · Phase I
- Topic
- AF191-005
- Solicitation
- 19.1
- NAICS
- —
- Place of performance
- CA
- Period
- 2019-03-06 → 2019-06-04
Description
AeBeZe Labs specializes in digital therapeutics–tools, techniques, and technology engineered to combat anxiety and the earliest signs of depression. Our purely digital product suite is uniquely designed to elevate mood, and maintain it over time, using a combination of proven science and patent-pending technology to improve behavioral health outcomes at the population level. Using a combination of curation (of existing materials) and creation (of original materials), both backed by existing scientific literature, we deliver content specifically designed to help improve mood. AeBeZe digital therapeutics are delivered through interactive mobile cards, activities, and programs that activate 6 neurotransmitters or compounds including: GABA, Dopamine, Serotonin, Acetylcholine, Endorphins, and Oxytocin.